Year |
Citation |
Score |
2020 |
Hamilton JZ, Pires TA, Mitchell JA, Cochran JH, Emmerton KK, Zaval M, Stone IJ, Anderson ME, Jin S, Waight AB, Lyon RP, Senter PD, Jeffrey SC, Burke PJ. Improving Antibody-Tubulysin Conjugates Through Linker Chemistry and Site-Specific Conjugation. Chemmedchem. PMID 33369163 DOI: 10.1002/cmdc.202000889 |
0.316 |
|
2018 |
Burke PJ, Hamilton JZ, Pires TA, Lai HWH, Leiske CI, Emmerton KK, Waight AB, Senter PD, Lyon RP, Jeffrey SC. Glucuronide-linked antibody-tubulysin conjugates display activity in MDR+ and heterogeneous tumor models. Molecular Cancer Therapeutics. PMID 29866744 DOI: 10.1158/1535-7163.MCT-18-0073 |
0.308 |
|
2013 |
Kung Sutherland MS, Walter RB, Jeffrey SC, Burke PJ, Yu C, Kostner H, Stone I, Ryan MC, Sussman D, Lyon RP, Zeng W, Harrington KH, Klussman K, Westendorf L, Meyer D, et al. SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood. 122: 1455-63. PMID 23770776 DOI: 10.1182/blood-2013-03-491506 |
0.32 |
|
2009 |
Burke PJ, Senter PD, Meyer DW, Miyamoto JB, Anderson M, Toki BE, Manikumar G, Wani MC, Kroll DJ, Jeffrey SC. Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues. Bioconjugate Chemistry. 20: 1242-50. PMID 19469529 DOI: 10.1021/bc9001097 |
0.303 |
|
2009 |
Burke PJ, Toki BE, Meyer DW, Miyamoto JB, Kissler KM, Anderson M, Senter PD, Jeffrey SC. Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system. Bioorganic & Medicinal Chemistry Letters. 19: 2650-3. PMID 19386499 DOI: 10.1016/j.bmcl.2009.03.145 |
0.334 |
|
2004 |
Burke PJ, Kalet BT, Koch TH. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells. Journal of Medicinal Chemistry. 47: 6509-18. PMID 15588086 DOI: 10.1021/Jm049496B |
0.485 |
|
2004 |
Burke PJ, Koch TH. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells. Journal of Medicinal Chemistry. 47: 1193-206. PMID 14971899 DOI: 10.1021/Jm030352R |
0.681 |
|
2004 |
Itharat A, Houghton PJ, Eno-Amooquaye E, Burke PJ, Sampson JH, Raman A. In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer Journal of Ethnopharmacology. 90: 33-38. PMID 14698505 DOI: 10.1016/j.jep.2003.09.014 |
0.323 |
|
2001 |
Burke PJ, Koch TH. Doxorubicin-formaldehyde conjugate, doxoform: induction of apoptosis relative to doxorubicin. Anticancer Research. 21: 2753-60. PMID 11724351 |
0.586 |
|
2001 |
Kato S, Burke PJ, Koch TH, Bierbaum VM. Formaldehyde in human cancer cells: detection by preconcentration-chemical ionization mass spectrometry. Analytical Chemistry. 73: 2992-7. PMID 11467545 DOI: 10.1021/Ac001498Q |
0.597 |
|
2000 |
Kato S, Burke PJ, Fenick DJ, Taatjes DJ, Bierbaum VM, Koch TH. Mass spectrometric measurement of formaldehyde generated in breast cancer cells upon treatment with anthracycline antitumor drugs. Chemical Research in Toxicology. 13: 509-16. PMID 10858324 DOI: 10.1021/Tx000008M |
0.622 |
|
1984 |
Karp JE, Burke PJ, Saylor PL, Humphrey RL. Correlation of Proliferative and Clonogenic Tumor Cells in Multiple Myeloma Cancer Research. 44: 4197-4200. PMID 6744329 |
0.323 |
|
Show low-probability matches. |